Plataforma de Servicios Biotecnológicos

What Plataforma de Servicios Biotecnológicos does

Plataforma de Servicios Biotecnológicos is a private, for-profit biotechnology services company headquartered in Bernal, Argentina. Founded in 2013, the firm is described as offering biotechnological services with a focus on bioprocesses and biosimilar biocomparability — capabilities typically directed at pharmaceutical manufacturers, biosimilar developers, and research organizations that require comparability studies, process development, or analytical support for biologic products. The geographic base in Bernal (within the Quilmes partido of Buenos Aires Province) places the firm within Argentina's cluster of life sciences activity.

Reported headcount stands at 51–100 employees, consistent with a laboratory- and project-based operating model that pairs technical staff in process development and analytical methods with quality/regulatory functions. The company's website (psbunq.com) was accessible only as a loading/verification placeholder at the time of data collection, and no proprietary technology descriptions, service catalog, certifications, patents, management roster, or client disclosures are available in the source material. Consequently, the specific platform architecture, equipment footprint, and technical methodologies cannot be characterized from the input.

No pricing model, go-to-market motion, customer segments, revenue figures, funding history, ownership structure, partnerships, or geographic reach beyond the Bernal base are disclosed. The absence of substantive web content and external coverage suggests limited public-market visibility, and any commercial or competitive assessment of the firm must be qualified by these data gaps.

Name

Plataforma de Servicios Biotecnológicos

Website

https://psbunq.com

Company type

Private

Founded year

2013

Headcount range

51–100 employees

Short description

Plataforma de Servicios Biotecnológicos is an Argentine biotechnology services firm, founded in 2013, offering bioprocess development and biosimilar biocomparability services to pharmaceutical and biotech clients. It operates from Bernal, Argentina, with 51–100 employees.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Contract Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (541380)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE)

Keywords

• Bioprocess development services
• Biosimilar comparability studies
• Biopharmaceutical analytical services
• Biologics characterization services
• Biotechnology contract services

Headquarters

HQ city

Bernal

HQ country

Argentina

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Core offering

Plataforma de Servicios Biotecnológicos is an Argentine contract services firm that provides biotechnological services, including bioprocess work and biosimilar biocomparability studies for biopharmaceutical developers. The company supports clients developing biologic drugs and biosimilars through laboratory and process-related activities rather than manufacturing or selling its own therapeutic products.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioprocess services Outsourced bioprocess support work delivered to biopharmaceutical developers, based on the company's stated biotechnological services offering.
• Biosimilar biocomparability services Comparability studies and related analytical work to demonstrate biosimilarity between a candidate biosimilar and its reference biologic, supporting regulatory submissions by biosimilar developers.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Celltrion: South Korean biosimilar developer and manufacturer with strong in-house comparability and process capabilities; comparable as a biosimilar-focused organization operating across the same value chain.
• Selvita: Mid-sized European CRO/CDMO offering process development and analytical services for biologics; comparable in scale and service mix to a university-affiliated biotech services platform.
• mAbxience: Argentine-headquartered biosimilar and biologics CDMO; the closest direct peer given shared geography (Buenos Aires region) and overlap in biosimilar development services for global clients.
• Samsung Bioepis: Biosimilar-focused developer with deep comparability and process development capabilities; comparable because both companies operate in the biosimilar value chain with emphasis on analytical biocomparability.

Others

• Cytiva: Supplier of bioprocess equipment, resins, and process development services for biologics manufacturers; comparable as an ecosystem participant supplying tools used in the same biosimilar development workflows.
• Sartorius Stedim Biotech: Supplier of bioprocess technologies, consumables, and services used in upstream/downstream bioprocessing; included as an adjacent enabling vendor whose customer base overlaps with Plataforma's.

Broad incumbents

• WuXi Biologics: Global end-to-end biologics CDMO offering biosimilar process development and comparability services at scale; relevant as the large-scale incumbent that defines competitive benchmarks and pricing pressure for niche players like Plataforma.
• Lonza Biologics: World's largest biologics CDMO with substantial biosimilar manufacturing and process development offerings; included as a broad incumbent shaping the competitive landscape for mid-sized biosimilar service providers.
• Boehringer Ingelheim BioXcellence: Global biologics CDMO with biosimilar process development and manufacturing; relevant as a broad incumbent competing for the same biologics development programs.

Emerging players

• Stelis Biopharma: Emerging biologics CDMO focused on process development and manufacturing for biosimilars and novel biologics; relevant as a peer at similar scale pursuing comparable service offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plataforma de Servicios Biotecnológicos